Companies
- Companies
- Browse
Companies
Transforming special needs into big achievements - in urology, rheumatology, gynecology, neurology and other indications More
The CEI is the technology transfer department of the University of Southampton. We are responsible for IP protection, licenses, spinouts and entrepreneurship throughout the University More
Contract In house Support by experienced Cintas Pharma Associates to offer Pharmaceutical Development/Regulatory Services More
Quality Translations for Science, Industry, Government since 1957 More
MediCHIP - a technology transfer organisation. We identify, develop and commercialize IP arising from healthcare innovations. More
CryoLife Inc (NYSE-CRY) formed AuraZyme(TM), a wholly owned subsidiary, to foster development of its propietary A-Z-CINN(tm) Linker for creating better targeted drug delivery systems. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2008 - 175 pages - $3,835
Jan 2011 - 124 pages - $1,740
Apr 2007 - 118 pages - $2,495
Oct 2010 - 97 pages - $3,835
Jun 2009 - 472 pages - $3,140
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Dec 2006 - 90 pages - $995
Jun 2009 - 110 pages - $1,040
Nov 2010 - 97 pages - $600
Your selection
Browse By
- Industry sector
- Dermatological
- Oral
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us